Information:
Fel:
ID
13218
Beskrivning
Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT02177331
Länk
https://clinicaltrials.gov/show/NCT02177331
Nyckelord
Versioner (1)
- 2016-01-24 2016-01-24 -
Uppladdad den
24 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hypertension NCT02177331
Eligibility Hypertension NCT02177331
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT02177331
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
fulfillment of entry criteria for the preceding yearly study
boolean
Age
Item
male or female patients aged between 20 and 85 years
boolean
C0001779 (UMLS CUI [1])
essential hypertension. who grade
Item
known history of mild to moderate essential hypertension requiring drug treatment, who grade i to ii
boolean
C0085580 (UMLS CUI [1,1])
C0013216 (UMLS CUI [1,2])
C0020538 (UMLS CUI [2,1])
C0013216 (UMLS CUI [2,2])
C0013216 (UMLS CUI [1,2])
C0020538 (UMLS CUI [2,1])
C0013216 (UMLS CUI [2,2])
blood pressure, lacidipine
Item
controlled blood pressure (rr diastolic ≤ 90 mm hg or 91 - 95 mm hg and concurrent reduction in blood pressure of at least 10 mm compared to baseline level) during treatment with lacidipine at a dose of 2 - 6 mg once a day
boolean
C0005823 (UMLS CUI [1])
C0064568 (UMLS CUI [2])
C0064568 (UMLS CUI [2])
ID.5
Item
final visit of the previous yearly study (visit 4) completed as scheduled
boolean
informed consent
Item
informed consent to participate in the follow-up study
boolean
C0021430 (UMLS CUI [1])
ID.7
Item
violation of entry/exclusion criteria on enrolment in the preceding yearly study
boolean
ID.8
Item
occurrence of the following exclusion criteria in the intervening period:
boolean
pregnancy, lactation, possibility of conception
Item
pregnancy, lactation, possibility of conception without the use of a scientifically recognised method of contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
secondary hypertension
Item
secondary form of hypertension
boolean
C0155616 (UMLS CUI [1])
consumptive illness
Item
consumptive illness
boolean
C0009488 (UMLS CUI [1])
cardiovascular disease
Item
clinically manifest concomitant cardiovascular illness, e.g.: aortic or mitral valve stenosis, hypertrophic obstructive cardiomyopathy or any other condition hindering left ventricular outflow, aortic isthmus stenosis, severe (nyha class iii or higher) or decompensated heart failure, clinically relevant hypo- or hyperkinetic cardiac arrhythmia
boolean
C0007222 (UMLS CUI [1])
myocardial infarction, cerebrovascular accident
Item
myocardial infarction or cerebrovascular accident within the 6 months prior to the start of the follow-up study
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
hypersensitivity to dihydropyridines
Item
hypersensitivity to dihydropyridines
boolean
C0020517 (UMLS CUI [1,1])
C0012315 (UMLS CUI [1,2])
C0012315 (UMLS CUI [1,2])
antihypertensive agents, sedatives, tricyclic antidepressants
Item
concomitant long-term treatment (> 3 weeks) with antihypertensive substances not envisaged in the protocol (exception: short-acting nitrates), sedatives, tricyclic antidepressants
boolean
C0003364 (UMLS CUI [1])
C0036557 (UMLS CUI [2])
C0003290 (UMLS CUI [3])
C0036557 (UMLS CUI [2])
C0003290 (UMLS CUI [3])
suspected alcohol, narcotic or drug abuse
Item
suspected alcohol, narcotic or drug abuse
boolean
C0038586 (UMLS CUI [1])